NSRX
Nasus Pharma Ltd.
NYSE MKT: NSRX · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$2.75
+1.85% today
Updated 2026-05-01
Market cap
$37.24M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $10
Volume
0.2M
Nasus Pharma Ltd. (NSRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 4
Last 4 quarters
Avg EPS surprise
+50.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.8%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-6.5%
2025-12-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $0.00 | +100.0% | $5.26 | $5.10 | -3.0% |
| 2025-12-03 | $-0.14 | +0.0% | $7.33 | $6.85 | -6.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.53 | $0.00 | +100.0% | — | — |
| 2025-09-30 | $-0.14 | $-0.14 | +0.0% | — | — |
| 2025-06-30 | $0.00 | $-0.09 | — | — | — |
| 2024-12-31 | $0.00 | $-0.09 | — | — | — |
Frequently asked questions
Has Nasus Pharma Ltd. beaten earnings estimates?
Nasus Pharma Ltd. has beaten Wall Street EPS estimates in 2 of its last 4 quarterly reports, with an average EPS surprise of +50.0% over the last 2 quarters.
How does NSRX stock react to earnings?
NSRX stock has moved an average of -4.8% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.